nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.082	0.0875	CbGpPWpGaD
Acepromazine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0644	0.0687	CbGpPWpGaD
Acepromazine—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0402	0.0429	CbGpPWpGaD
Acepromazine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0327	0.0349	CbGpPWpGaD
Acepromazine—DRD1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0229	0.0245	CbGpPWpGaD
Acepromazine—HTR1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0197	0.0211	CbGpPWpGaD
Acepromazine—DRD1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0193	0.0206	CbGpPWpGaD
Acepromazine—ADRA1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0188	0.0201	CbGpPWpGaD
Acepromazine—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0173	0.0185	CbGpPWpGaD
Acepromazine—HTR2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.017	0.0182	CbGpPWpGaD
Acepromazine—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0167	0.0178	CbGpPWpGaD
Acepromazine—HTR1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0166	0.0177	CbGpPWpGaD
Acepromazine—ADRA1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0158	0.0169	CbGpPWpGaD
Acepromazine—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0146	0.0155	CbGpPWpGaD
Acepromazine—HTR2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0143	0.0153	CbGpPWpGaD
Acepromazine—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.014	0.015	CbGpPWpGaD
Acepromazine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0129	0.0138	CbGpPWpGaD
Acepromazine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.012	0.0128	CbGpPWpGaD
Acepromazine—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0115	0.0123	CbGpPWpGaD
Acepromazine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0102	0.0109	CbGpPWpGaD
Acepromazine—Propiomazine—CHRM3—nephrolithiasis	0.00982	0.155	CrCbGaD
Acepromazine—Chlorprothixene—CHRM3—nephrolithiasis	0.00929	0.147	CrCbGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00845	0.00902	CbGpPWpGaD
Acepromazine—HTR1A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0084	0.00897	CbGpPWpGaD
Acepromazine—Methotrimeprazine—CHRM3—nephrolithiasis	0.00839	0.133	CrCbGaD
Acepromazine—Promethazine—CHRM3—nephrolithiasis	0.00827	0.131	CrCbGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00773	0.00825	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00773	0.00825	CbGpPWpGaD
Acepromazine—HTR2A—GPCRs, Other—CHRM3—nephrolithiasis	0.00757	0.00808	CbGpPWpGaD
Acepromazine—Desipramine—CHRM3—nephrolithiasis	0.00751	0.119	CrCbGaD
Acepromazine—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00738	0.00788	CbGpPWpGaD
Acepromazine—DRD1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00728	0.00777	CbGpPWpGaD
Acepromazine—Promazine—CHRM3—nephrolithiasis	0.00728	0.115	CrCbGaD
Acepromazine—ADRA1B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00649	0.00693	CbGpPWpGaD
Acepromazine—Chlorpromazine—CHRM3—nephrolithiasis	0.0064	0.101	CrCbGaD
Acepromazine—Imipramine—CHRM3—nephrolithiasis	0.00637	0.101	CrCbGaD
Acepromazine—HTR2A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00589	0.00628	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00586	0.00625	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00586	0.00625	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0058	0.0062	CbGpPWpGaD
Acepromazine—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00576	0.00615	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00565	0.00604	CbGpPWpGaD
Acepromazine—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00563	0.00601	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00545	0.00581	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00545	0.00581	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00526	0.00562	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00517	0.00552	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00517	0.00552	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00516	0.0055	CbGpPWpGaD
Acepromazine—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.005	0.00534	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00485	0.00518	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00482	0.00514	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00482	0.00514	CbGpPWpGaD
Acepromazine—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00469	0.00501	CbGpPWpGaD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00443	0.00473	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00429	0.00458	CbGpPWpGaD
Acepromazine—HTR2A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00426	0.00454	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0042	0.00448	CbGpPWpGaD
Acepromazine—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00417	0.00445	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00393	0.00419	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00393	0.00419	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00392	0.00418	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00392	0.00418	CbGpPWpGaD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00381	0.00407	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00381	0.00406	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00379	0.00405	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00373	0.00398	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0037	0.00395	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00364	0.00389	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00364	0.00389	CbGpPWpGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00363	0.00387	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00334	0.00357	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00334	0.00357	CbGpPWpGaD
Acepromazine—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00329	0.00351	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00326	0.00348	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00325	0.00347	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00322	0.00344	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00322	0.00344	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00322	0.00344	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00311	0.00332	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.00304	0.00324	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00298	0.00318	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00298	0.00318	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00289	0.00308	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00288	0.00307	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00287	0.00307	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00286	0.00306	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00282	0.00301	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00277	0.00295	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00277	0.00295	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00276	0.00295	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00274	0.00292	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—PTH—nephrolithiasis	0.00264	0.00282	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00263	0.00281	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00263	0.00281	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00261	0.00279	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00252	0.00269	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00249	0.00265	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00248	0.00265	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00248	0.00265	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00247	0.00263	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00247	0.00263	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00243	0.0026	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00237	0.00253	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00229	0.00245	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.00227	0.00243	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00226	0.00241	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00226	0.00241	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00221	0.00236	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00218	0.00233	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.00216	0.00231	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00215	0.00229	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.00211	0.00225	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.0021	0.00224	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.00205	0.00219	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.002	0.00213	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00199	0.00213	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00199	0.00213	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00197	0.00211	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.00196	0.0021	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00194	0.00207	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00192	0.00205	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00191	0.00203	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—DGKH—nephrolithiasis	0.00191	0.00203	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00185	0.00198	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00185	0.00198	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00185	0.00197	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00181	0.00194	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.00179	0.00191	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00176	0.00188	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.00173	0.00184	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.00171	0.00183	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00171	0.00182	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00168	0.00179	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00168	0.00179	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00165	0.00176	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00165	0.00176	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00164	0.00175	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00163	0.00174	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.00159	0.0017	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00157	0.00167	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.00155	0.00165	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.00154	0.00165	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00153	0.00164	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.00152	0.00163	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00152	0.00163	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.00149	0.00159	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00149	0.00159	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00148	0.00158	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.00147	0.00157	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0014	0.0015	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—PTH—nephrolithiasis	0.00136	0.00145	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.00135	0.00145	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00134	0.00143	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.00133	0.00142	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00132	0.00141	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.0013	0.00139	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.0013	0.00138	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—APRT—nephrolithiasis	0.0013	0.00138	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00128	0.00137	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00128	0.00136	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00123	0.00132	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.00122	0.00131	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00121	0.0013	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00121	0.00129	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DGKH—nephrolithiasis	0.00121	0.00129	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00121	0.00129	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00119	0.00127	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.00117	0.00124	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GRHPR—nephrolithiasis	0.00114	0.00122	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.00113	0.0012	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00112	0.0012	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.00111	0.00119	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00111	0.00118	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.0011	0.00118	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00109	0.00116	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00108	0.00115	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00104	0.00111	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.00104	0.00111	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.00102	0.00109	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AGXT—nephrolithiasis	0.00102	0.00109	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.00101	0.00108	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000992	0.00106	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000992	0.00106	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000986	0.00105	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.000924	0.000986	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000915	0.000977	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000915	0.000977	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.0009	0.000961	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0009	0.000961	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000881	0.000941	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000881	0.000941	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000876	0.000935	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APRT—nephrolithiasis	0.000867	0.000926	CbGpPWpGaD
Acepromazine—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000867	0.000926	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000835	0.000892	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PTH—nephrolithiasis	0.000801	0.000855	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000753	0.000804	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000717	0.000766	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000689	0.000735	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000661	0.000706	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000656	0.0007	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000651	0.000695	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000637	0.00068	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AQP1—nephrolithiasis	0.000618	0.00066	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000605	0.000646	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.000595	0.000635	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000583	0.000622	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CHRM3—nephrolithiasis	0.000559	0.000597	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000402	0.000429	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	0.000346	0.000369	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.000329	0.000352	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000304	0.000324	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	0.000299	0.000319	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000293	0.000312	CbGpPWpGaD
